Skip to main content

Table 1 Demographic and clinical characteristics at baseline

From: Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studies

Characteristic

Diabetic peripheral neuropathy

Postherpetic neuralgia

 

Placebo

(n = 558)

Pregabalin

150 mg/day

(n = 176)

Pregabalin

300 mg/day

(n = 266)

Pregabalin

600 mg/day

(n = 513)

Placebo

(n = 363)

Pregabalin

150 mg/day

(n = 251)

Pregabalin

300 mg/day

(n = 230)

Pregabalin

600 mg/day

(n = 159)

Male, n (%)

308 (55.2)

110 (62.5)

144 (54.1)

309 (60.2)

180 (49.6)

117 (46.6)

103 (44.8)

76 (47.8)

   Age, n (%)

        

18-64 y

366 (65.6)

127 (72.2)

182 (68.4)

344 (67.1)

68 (18.7)

57 (22.7)

45 (19.6)

47 (29.5)

65-74 y

158 (28.3)

39 (22.2)

62 (23.3)

139 (27.1)

143 (39.4)

92 (36.6)

64 (27.8)

69 (43.4)

≥75 y

34 (6.1)

10 (5.7)

22 (8.3)

30 (5.8)

152 (41.9)

102 (40.6)

121 (52.6)

43 (27.0)

   Race

        

White

496 (88.9)

167 (94.9)

243 (91.4)

460 (89.7)

354 (97.5)

244 (97.6)

226 (99.1)

154 (96.9)

Black

28 (5.0)

3 (1.7)

10 (3.8)

22 (4.3)

2 (0.5)

4 (1.6)

2 (0.9)

1 (0.6)

Hispanic

24 (4.3)

2 (1.1)

7 (2.6)

20 (3.9)

4 (1.1)

2 (0.8)

1 (0.4)

4 (2.5)

Asian or Pacific Islander

2 (0.4)

2 (1.1)

3 (1.1)

5 (1.0)

2 (0.5)

1 (0.4)

0

0

Alaskan or Native American

1 (0.2)

0

1 (0.4)

0

0

0

0

0

Other

7 (1.3)

2 (1.1)

2 (0.8)

6 (1.2)

1 (0.3)

0

1 (0.4)

0

   Weight, kg, mean (SD)

92.6 (20.6)

91.1 (17.8)

93.6 (20.1)

93.1 (19.8)

74.7 (15.7)

73.9 (15.6)

69.8 (13.6)

77.8 (13.9)

   Height, cm, mean (SD)

170.8 (10.1)

172.3 (10.2)

171.4 (10.1)

171.2 (9.9)

167.0 (9.9)

165.5 (9.8)

165.3 (10.5)

166.3 (11.1)

   CLcr, mL/min

        

Mean (SD)

101.9 (37.3)

101.0 (33.0)

101.7 (36.7)

98.5 (30.3)

69.9 (26.5)

68.7 (24.3)

63.2 (24.3)

84.8 (22.3)

N

554

175

265

511

362

250

230

156

   Baseline paina

        

Mean (SD)

6.5 (1.6)

6.3 (1.4)

6.4 (1.4)

6.6 (1.6)

6.6 (1.5)

6.6 (1.6)

6.8 (1.5)

6.5 (1.5)

N

550

175

265

508

361

250

230

154

   Baseline sleepb

        

Mean (SD)

5.3 (2.4)

5.1 (2.4)

5.6 (2.2)

5.4 (2.6)

4.6 (2.7)

4.5 (2.5)

4.8 (2.6)

4.8 (2.4)

N

549

175

265

508

361

250

230

154

  1. a Daily Pain Rating Scale score
  2. b Daily Sleep Interference Scale score
  3. SD: standard deviation; CLcr: creatinine clearance